Skip to content

Speech Therapy in the Management of Chronic Cough

Speech Therapy in the Management of Difficult-to-treat Chronic Cough

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03457610
Enrollment
30
Registered
2018-03-07
Start date
2016-01-01
Completion date
2020-01-30
Last updated
2020-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough, Speech Therapy

Keywords

chronic cough, speech and language intervention, difficult-to-treat cough

Brief summary

Speech and language intervention (speech therapy) is one of the few methods which seem to be useful in management of persistent chronic cough. This method has not been available for patients with cough in Poland so far.The aim of the study is to implement speech therapy to the management plan of patients with difficult-to-treat chronic cough and to analyze its efficacy in this particular group. Patients with difficult-to treat chronic cough will be offered speech and language intervention as an added therapy. The effectiveness of speech therapy will be measured by changes in cough severity, its influence on quality of life and cough challenge test before and after speech therapy measured in every patient.

Detailed description

The efficacy of management of chronic cough in adults is limited. Speech and language intervention (speech therapy) is one of the few methods which seem to be useful in management of persistent chronic cough. This method has not been available for patients with cough in Poland so far. The aim of the study is to implement speech therapy to the management plan of patients with difficult-to-treat chronic cough and to analyze its efficacy in this particular group. Patients, who are diagnosed and unsuccessfully managed because of difficult-to treat chronic cough, will be offered speech and language intervention as an added therapy. It is based on the technique described by Vertigan et al.The entire therapy will consist of eight sessions once a week. Cough severity, its influence on quality of life and cough challenge test with capsaicin will be assessed by Visual Analogue Scale, Leicester Cough Questionnaire and cough challenge test with capsaicin will be performed before and after speech therapy in every patient to analyze its effectiveness

Interventions

BEHAVIORALSpeech and language intervention

Speech therapy includes education about cough and vocal hygiene, teaching strategies to reduce cough, breathing and vocal exercises. The whole therapy consists of eight sessions once a week.

Sponsors

Medical University of Warsaw
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

prospective, single arm, single center study

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. age between 18 and 80 years, 2. chronic cough lasting more than six months 3. earlier thorough diagnosing of cough reason 4. unsuccessful cough management despite at least 3 months of earlier treatment 5. no symptoms of any airway infection during last 4 weeks.

Exclusion criteria

1. lack of opportunity to participate in speech therapy sessions 2. cough lasting less than 6 months 3. active cigarette smoking 4. taking ACE inhibitors 5. symptoms of airway infection (other than cough).

Design outcomes

Primary

MeasureTime frameDescription
Cough severity3 monthsmeasured by Visual Analogue Scale (VAS), range 0-100 mm, the more severe cough , the higher value in VAS score

Secondary

MeasureTime frameDescription
Cough related quality of life3 monthsmeasured by Leicester Cough Questionnaire (LCQ)- health related Quality of Life Questionnaire dedicaated for patients, who cough; rangeof total LCQ is 3 to 21 points; higher values represent less intense cough
Sensitivity of cough reflex3 monthsmeasured by cough challenge test with capsaicin

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026